Full-Time

Manager – Quality Control Scheduling

Posted on 9/17/2024

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Biotechnology
Healthcare

Junior, Mid

Norwood, MA, USA

70% in-office structure.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Requirements
  • Education: BA/BS Degree
  • Experience: 2 to 3 years of experience of planning in QC Laboratories planning inside a Supply Chain or QA organizations.
Responsibilities
  • Work directly with the project management, supply chain, QA and manufacturing teams to capture all required commercial and clinical lot testing needs for the site.
  • Develop the laboratory testing schedule to meet demand and communicate capacity constraints.
  • Responsible for the maintenance and continuous improvement of Scheduling software systems.
  • Create and maintain detailed plan to support the testing needs of the stability and technical development groups.
  • Lead meetings with QC laboratory sub-teams to align and facilitate discussions on priorities, quality events and overall deliverables.
  • Communicate KPI’s and metrics that track the effectiveness of planning and testing execution.
  • Serve as a point of contact for information requests on status into the QC team and respond, or route accordingly.
  • Follow all relevant GxP regulations, guidelines, and company policies to ensure compliance with regulatory and internal requirements.
  • Execute tasks precisely as defined in internal guiding documents including but not limited to standard operating procedures (SOPs) and work instructions.
  • Follow Good Documentation Practices and Data Integrity requirements to ensure data, documentation, and records are completed and maintained for use by the business and available to support audits or inspections.
  • Complete training in assigned required learning plan according to the defined timing and the prescribed requalification cadence.
  • Additional duties as may be assigned from time to time

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for various biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on small molecules or proteins, Moderna's mRNA-based therapies aim to enhance the speed and efficiency of drug discovery and manufacturing. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments for a range of health conditions.

Company Stage

IPO

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

2010

Growth & Insights
Headcount

6 month growth

4%

1 year growth

15%

2 year growth

48%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's AI-driven drug discovery accelerates novel mRNA-based therapeutics identification.
  • Expansion in Asia enhances global supply chain and reduces production costs.
  • mRNA technology is gaining traction for non-infectious disease vaccines, like cancer.

What critics are saying

  • Potential Nasdaq 100 removal could impact stock visibility and investor interest.
  • Bypassing safety steps in Australia may raise regulatory and public scrutiny concerns.
  • Hong Kong's reluctance to receive Covid-19 jab affects market penetration and sales.

What makes Moderna unique

  • Moderna is pioneering mRNA technology for a new class of medicines.
  • The company focuses on mRNA's potential to transform drug discovery and manufacturing.
  • Moderna's mRNA platform enables rapid development of vaccines and therapeutics.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE